Mark McClellan
Mark McClellan
Mark Barr McClellanis the Director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University. Formerly, he was a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at The Brookings Institution, in Washington, D.C. McClellan served as Commissioner of the United States Food and Drug Administration under President George W. Bush from 2002 through 2004,...
benefit leaves needs sure work
The benefit needs to work for everyone. We're working ... to make sure that no one leaves without the prescriptions that they need.
diseases money paying
It just doesn't make sense for us to be paying that much money on complications of diseases we can prevent.
help medicare people start thinking time
It's time for people with Medicare and those who care about them to start thinking about making Medicare decisions. And we will help them.
continue december faster late saw seen steady
We've seen enrollment continue at a steady pace, faster than what we saw before the late December surge.
finding fixing people problems satisfied
Our surveys show that, 5-to-1, people are very satisfied with the program. For people who have had problems, we're finding the problems and fixing them.
advantage help interested resources savings saying senior taking worth
They are overwhelmingly saying it is worth the effort, and they will get savings and security, and in many cases, more savings than they expected. And we have the resources to help any other senior who is interested in taking advantage of the same program.
acute adult assistant care clearly coordinate health programs seems services
Adult day care programs (and) assistant programs like that clearly have a big impact. It seems like it would make sense to coordinate those services with acute health care.
coverage people start understanding
People need to start by understanding what kind of coverage they have now.
benefit concerns coverage medicare
CMS has significant concerns about the GAO's finding. These individuals will get effective, comprehensive prescription-drug coverage when the new Medicare prescription-drug benefit begins.
evidence immediate leave plan
They'll be able to leave the pharmacy with their prescription in hand, even if there is not immediate evidence of what plan they're in.
care colorado committing health pleased
I am pleased to see Colorado committing to the health care of children.
benefits coming costs
The costs are coming in lower, the benefits are coming in better than expected.
choices outcomes information
Food choices affect health outcomes, and consumers need to have the latest, most up-to-date scientific information in making their food choices.
real light medicine
Pharmacogenomics holds great promise to shed scientific light on the often risky and costly process of drug development, and to provide greater confidence about the risks and benefits of drugs in specific populations. Pharmacogenomics is a new field, but we intend to do all we can to use it to promote the development of medicines. By providing practical guidance on how to turn the explosion of pharmacogenomic information into real evidence on new drugs, we are taking an important step toward that goal.